DiagNovus IVS
CVR 38618482 · Entrepreneurial company (IVS) · Dissolved by declaration
DiagNovus IVS is a Entrepreneurial company (IVS), founded on , based in København S. The company is registered in the industry forskning og eksperimentel udvikling indenfor bioteknologi. The company is no longer active (status: dissolved by declaration). 1 annual report has been published. The latest annual report (31 Dec 2017) shows equity of DKK 1 and a net result of DKK 0.
Company details
- CVR number
- 38618482
- Status
- Dissolved by declaration
- Company type
- Entrepreneurial company (IVS)
- Founded
- Ceased
- Address
- c/o Emil Arvedsen, Holmbladsgade 58, 3. tv
2300 København S - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 1
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 100.0% |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 1 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2017 |
|---|---|
| Revenue | DKK 0 |
| Gross profit | DKK 0 |
| Net profit | DKK 0 |
| Equity | DKK 1 |
| Total assets | DKK 1 |
| Cash | DKK 0 |
| Short-term debt | DKK 0 |
| Tax owed | DKK 0 |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 4 May 2017 – 31 Dec 2017 | 75 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Emil Arvedsen | ||
| CEO | Philip Hassing Ronøe Carlsen | ||
| CEO | Jannik Faliu | ||
| Owner (33%) | Emil Arvedsen | ||
| Owner (33%) | Philip Hassing Ronøe Carlsen | ||
| Owner (33%) | Jannik Faliu | ||
| Founder | Emil Arvedsen | ||
| Founder | Philip Hassing Ronøe Carlsen | ||
| Founder | Jannik Faliu |
The CEOs' other companies
Emil Arvedsen – 3 other companies
- Arvedsen & Faliu Holding ApS Active
- Immunordic ApS Active
- Oncleave Therapeutics ApS Active
Jannik Faliu – 3 other companies
- Arvedsen & Faliu Holding ApS Active
- Immunordic ApS Active
- Oncleave Therapeutics ApS Active
Address history (0 moves)
| c/o Emil Arvedsen, Holmbladsgade 58, 3. tv, 2300 København S |
Other companies at the same address
- A Brenda IVS Opløst
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about DiagNovus IVS
Has DiagNovus IVS gone bankrupt?
No, DiagNovus IVS is not registered as bankrupt in the CVR register. Its status is: dissolved by declaration.
When was DiagNovus IVS founded?
DiagNovus IVS was founded on 4 May 2017.
What is the equity of DiagNovus IVS?
Equity was DKK 1 according to the annual report for the period ending 31 December 2017.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.